Gregory W Schafer's Net Worth
$4.96 Million
Who is Gregory W Schafer?
Gregory W Schafer has an estimated net worth of $4.96 Million. This is based on reported shares across multiple companies, which include ADURO BIOTECH, INC., CERUS CORP, Nile Therapeutics, Inc., ONYX PHARMACEUTICALS INC, and INTRABIOTICS PHARMACEUTICALS INC /DE.
SEC CIK
Gregory W Schafer's CIK is 0001193195
Past Insider Trading and Trends
2017 was Gregory W Schafer's most active year for acquiring shares with 16 total transactions. Gregory W Schafer's most active month to acquire stocks was the month of November. 2017 was Gregory W Schafer's most active year for disposing of shares, totalling 22 transactions. Gregory W Schafer's most active month to dispose stocks was the month of October. 2008 saw Gregory W Schafer paying a total of $292,240.00 for 137,100 shares, this is the most they've acquired in one year. In 2016 Gregory W Schafer cashed out on 235,905 shares for a total of $1,661,752.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ADURO BIOTECH, INC. No price found
Chief Operating OfficerGregory W Schafer owns 254,062 units of Common Stock. In the year 2015 Gregory W Schafer filed a total of 23 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.19% | 63.32K |
$0.78 | $49,233.17 | 254.06K |
Jan 25
| |||
Form 4
| +28.24% | 42K |
$4.25 | -$96,934.84 | 190.75K |
Scheduled
|
Dec 29 - Jan 2
| ||
Form 4
|
—
|
0
|
$5.19 | -$166,115.47 | 148.75K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$4.51 | -$138,544.84 | 148.75K |
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
$6.06 | -$187,912.20 | 148.75K |
Scheduled
|
Oct 2
| ||
Form 4
| +22.95% | 27.77K |
$10.99 | -$53,380.00 | 148.75K |
Sep 12 - Sep 13
| |||
Form 4
|
—
|
0
|
$6.47 | -$209,180.30 | 120.98K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$6.71 | -$437,162.93 | 120.98K |
Scheduled
|
Aug 7 - Aug 8
| ||
Form 4
|
—
|
0
|
$6.36 | -$392,568.00 | 120.98K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +40.71% | 35K |
$0.82 | $28,700.00 | 120.98K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
$8.12 | -$1,066,731.24 | 85.98K |
Scheduled
|
Nov 10 - Nov 11
| ||
Form 4
| +74.47% | 36.7K |
—
|
—
| 85.98K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| -1.80% | -905.00 |
$8.20 | -$7,421.00 | 49.28K |
Scheduled
|
May 16
| ||
Form 4
|
—
|
0
|
$12.29 | -$451,600.00 | 49.28K |
Scheduled
|
Jan 8
| ||
Form 4
| +43.76% | 15K |
$0.82 | $12,300.00 | 49.28K |
Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
$15.60 | -$707,321.00 | 34.28K |
Scheduled
|
Dec 7
| ||
Form 4
| -1.38% | -1.47K |
$14.80 | -$708,990.68 | 105.38K |
Scheduled
|
Nov 16 - Nov 17
| ||
Form 4
|
∞
| 34.28K |
—
|
—
| 34.28K |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CERUS CORP (CERS) Snapshot price: $2.04
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
| No matching records found | |||||||||
Nile Therapeutics, Inc. (CAPR) Snapshot price: $4.09
InvestorGregory W Schafer owns 100 units of Common Stock which is worth $409.00. In the year 2008 Gregory W Schafer filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
∞
| 100 |
$4.60 | $460.00 | 100 |
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONYX PHARMACEUTICALS INC No price found
CFOGregory W Schafer owns 9,747 units of Common Stock. From 2006 to 2008 Gregory W Schafer acquired a total of 27,000 shares in ONYX PHARMACEUTICALS INC at a cost of $325,173.75, Gregory also disposed a total of 19,561 shares of ONYX PHARMACEUTICALS INC equalling to $750,537.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$28.11 | -$237,900.00 | 9.75K |
Scheduled
|
Sep 18
| ||
Form 4
| -13.80% | -1.56K |
$37.50 | -$58,537.50 | 9.75K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
$26.36 | -$162,320.00 | 10.86K |
Scheduled
|
Jun 25
| ||
Form 4
| +38.17% | 3K |
—
|
—
| 10.86K |
Mar 31
| |||
Form 4
| +140.00% | 3.5K |
—
|
—
| 6K |
Mar 30
| |||
Form 4
|
∞
| 2.5K |
$13.36 | $33,393.75 | 2.5K |
Aug 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTRABIOTICS PHARMACEUTICALS INC /DE No price found
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||